Trials / Withdrawn
WithdrawnNCT00000330
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2 - 5
Buprenorphine/Naloxone Treatment for Opioid Dependence-Experiment II-2
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Colorado, Denver · Academic / Other
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the abuse liability and reinforcing effects of intravenous buprenorphine and buprenorphine/naloxone combinations in heroin-dependent volunteers
Detailed description
not available at this time
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Opioid-Related Disorders |
Timeline
- Start date
- 1999-10-01
- Primary completion
- 1999-11-01
- Completion
- 1999-11-01
- First posted
- 1999-09-21
- Last updated
- 2017-05-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00000330. Inclusion in this directory is not an endorsement.